1980 Results
Sort By:
Published on January 1, 2016
Sponsor: Bioo Scientific The NEXTflex™ Small RNA-Seq Kit v3 improves small RNA analysis by making the library prep protocol completely gel-free or allowing for low-input small RNA library preparation. This kit also reduces the biases associated with small RNA sequencing by using patent-pending randomized adapter technology, resulting in small RNA…
Published on January 1, 2016
Sponsor: Integrated DNA Technologies The xGen® Exome Research Panel v1.0 is for the analysis of the human exome via next-generation sequencing. A total of 429,826 probes span 39 Mb of the human genome, providing deep and uniform coverage of 19,396 genes. Using the xGen Exome Research Panel with xGen Lockdown®…
Published on December 21, 2015
GENEWIZ said today it will acquire the genomic services (GS) business of Beckman Coulter for an undisclosed price. Headquartered in Danvers, MA, Beckman Colter’s GS business provide sequencing services with bioinformatics solutions for healthcare businesses as well as academic institutions and government agencies worldwide. GENEWIZ said GS's Sanger sequencing, next-generation…
Published on December 14, 2015
Thermo Fisher Scientific will make a £5 million ($7.56 million) investment in Premaitha. The company will receive £3 million ($4.53 million) at the outset with further milestone payments expected over the next two years. This investment will enable Premaitha to offer enhanced commercial solutions to clinical laboratories across Europe and…
Published on December 4, 2015
An NIH-funded study led by scientists at Harvard Medical School that were part of the Pediatric Cardiovascular Genetics Consortium have found a link for a set of gene mutations in the development of congenital heart disease and various neurodevelopmental abnormalities in children—include cognitive, motor, social, and language impairments. “We're homing…
Published on December 1, 2015
Qiagen reports that an evaluation by the Broad Institute of MIT and Harvard has affirmed the performance of its GeneReader NGS system in detecting gene variants known to be clinically relevant in colorectal cancer. Product data compared favorably with the company’s therascreen RAS mutation tests based on real-time qPCR and…
Published on December 1, 2015
Sponsor: Qiagen The GeneReader NGS System is a complete sample to insight next-generation sequencing solution designed to deliver actionable results. GeneReader’s turntable design enables researchers to process multiple and independent flow cells in parallel, simultaneously offering staggered access and continuous loading of multiple flow cells. This design facilitates sample scalability…
Published on December 1, 2015
Sponsor: Chromatrap Chromatrap has launched a range of Chromatin Immunoprecipitation (ChIP)-validated antibodies, which are vital to modern epigenetic research. The use of high quality and specific ChIP-validated antibodies is essential for the success of a ChIP assay. Antibodies from other applications do not always work well in ChIP, which is…
Published on November 30, 2015
Human Longevity Inc. (HLI) said today it has acquired Cypher Genomics for an undisclosed price, in a deal that adds human genomic interpretation software solutions to the buyer’s offerings. Based in San Diego, Cypher Genomics is a genome informatics company that has developed and markets Mantis™, software designed to enable customers to…
Published on November 18, 2015
Thermo Fisher Scientific said today it will partner with Novartis and Pfizer to develop and commercialize a companion diagnostic for non-small cell lung cancer (NSCLC) across multiple drug development programs. The value of the collaboration was not disclosed. The companion diagnostic will be a multimarker, universal next-generation sequencing (NGS) oncology…
Published on November 10, 2015
Arguably, there are few things men look less forward to than the thought of prostate examination. The reasons for their trepidation range from the comical to somber reality of facing the second most common form of cancer among men worldwide—prostate cancer—with over 1.2 million cases diagnosed in 2012 alone. The…
Published on November 2, 2015
Tute Genomics said today it has acquired the human-genome interpretation company Knome for an undisclosed price. Co-founded by George Church, Ph.D., Knome provides human genome interpretation systems and services designed to help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Knome says its…
Published on November 2, 2015
The age of fast, accurate, and noninvasive cancer screening is rapidly becoming reality. The power of next-generation sequencing has allowed molecular diagnostic techniques to sample small amounts of blood for the genetic hallmarks of tumorigenesis. These liquid biopsy procedures, as they have been dubbed, typically search for circulating tumor DNA…
Published on October 30, 2015
In the dozen years since the sequencing of the human genome, the pace of innovation in genetic testing has exploded. We are now able to screen, diagnose, and monitor numerous medical conditions based on insights gleaned from lab tests based on genetic markers identifiable in a blood specimen. For many…
Published on October 15, 2015
Researchers from the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard have harnessed the power of next-generation sequencing to analyze a large collection of leukemia tissue samples. Using whole exome sequencing (WES), the investigators screened genetic material from more than 500 samples of chronic lymphocytic leukemia (CLL)…